Laurion Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Laurion Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-50,805	Closed	-$1.24M	–	714
2023 Q1	$1.24M	Sell	50,805 -1,095	-2%	-$24K	0.01%	295
2022 Q4	$1.11M	Sell	51,900 -971	-2%	-$20.7K	0.01%	328
2022 Q3	$949K	Buy	52,871 +2,793	+6%	+$36.7K	0.01%	374
2022 Q2	$482K	Sell	50,078 -340,615	-87%	-$4.28M	0.01%	337
2022 Q1	$6.58M	Buy	+390,693	New	+$5.77M	0.08%	145
2020 Q1	–	Sell	-28,163	Closed	-$242K	–	1171
2019 Q4	$242K	Buy	+28,163	New	+$101K	﹤0.01%	796
2017 Q4	–	Sell	-427,472	Closed	-$1.21M	–	1935
2017 Q3	$1.21M	Buy	+427,472	New	+$1.15M	0.01%	914

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Laurion Capital Management's ISEE Position: Q2 2023 in Review

Laurion Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 50,805 shares — an estimated $1.24M sold.

Laurion Capital Management first reported a position in ISEE in Q3 2017 and held it in 7 quarters. The position peaked at $6.58M in Q1 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

Laurion Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Laurion Capital Management sold 50,805 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $1.24M.
Laurion Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2017 and held it in 7 quarters.
Laurion Capital Management's IVERIC bio, Inc. Common Stock position peaked at $6.58M in Q1 2022.
256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.